Add BrightSurf on Google Email

New clues to autism: epigenetic study identifies RABGGTB as a novel candidate gene

A recent epigenetic study identified RABGGTB as a promising biomarker for autism spectrum disorder, revealing extensive DNA methylation abnormalities in key brain regions. The findings suggest that studying this gene could unlock new doors to understanding ASD and lead to future diagnostic breakthroughs.

SourceUniversity of Fukui·JournalPsychiatry and Clinical Neurosciences·TypeExperimental study·DateMay 21, 2025

Prader-Willi syndrome reveals unique link between genetics and psychiatric disorders

Researchers have synthesized cutting-edge findings on Prader-Willi syndrome, revealing its unique link to autism spectrum disorder and psychotic spectrum disorders. The condition's distinct genetic subtypes correlate with specific psychiatric outcomes, offering critical insights into the interplay between genetics and psychiatric vulne...

SourceGenomic Press·JournalGenomic Psychiatry·TypeLiterature review·DateMay 20, 2025

Study reveals how inherited genes help shape the course of cancer

A new study reveals that inherited germline genetic variants significantly influence the biology of tumors, altering protein activity, gene expression, and tumor interactions with the immune system. The research suggests that considering a patient's inherited DNA could refine diagnosis, risk prediction, and therapy selection.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalCell·TypeExperimental study·DateApr 14, 2025

Monica Hsiung Wojcik, MD, MPH, FAAP, FACMG is the recipient of the 2025 Dr. Michael S. Watson Genetic and Genomic Medicine Innovation Award from the ACMG Foundation for Genetic and Genomic Medicine

Dr. Monica Wojcik, a neonatologist and clinical geneticist, receives the prestigious award for her innovative research and clinical practice focused on rare diseases affecting fetuses and newborns. Her work aims to improve diagnosis, treatment, and health services for families affected by these conditions.

The ACMG Foundation for Genetic and Genomic Medicine presents four next generation Fellowship Awards at the 2025 ACMG Annual Clinical Genetics Meeting

The ACMG Foundation has presented four Next Generation Fellowship Awards to talented clinicians, researchers, and scientists. These winners are making significant impact in the field of genomics, advancing diagnosis, and patient care. The award recognizes their dedication to innovative approaches and commitment to improving healthcare ...

International Alliance for Primary Immunodeficiency Societies selects Rockefeller University Press to publish new Journal of Human Immunity

The International Alliance for Primary Immunodeficiency Societies has partnered with Rockefeller University Press to launch the Journal of Human Immunity, an open-access journal focused on human immunity and inborn errors of immunity. The journal aims to provide a platform for groundbreaking research and attract top-tier submissions.

Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model

Researchers found that bumetanide treatment normalizes neonatal social communication in newborn pups with the fragile X mutation, but reduces post-pubertal social interaction. The study suggests stage-specific effects on social development and raises questions about timing and dosing of bumetanide for targeted interventions.

SourceGenomic Press·JournalGenomic Psychiatry·DateDec 24, 2024

Study shows that Rett syndrome in females is not just less severe, but different

Researchers found that female mouse models of Rett syndrome have a mosaic-like distribution of cells expressing wild-type and mutant MeCP2 protein, leading to dysregulated genes. The study also discovered an unusual disease progression, with females having more dysregulated genes at the pre-symptomatic stage than later on.

SourceUniversity of California - Davis Health·JournalCommunications Biology·TypeExperimental study·DateOct 17, 2024

Searching for a vaccine against an ancient scourge

Researchers have conducted the largest genomic survey of the syphilis bacterium to date, correlating genetic data with clinical information to identify potential targets for a vaccine. The study found differences in bacterial strains between continents, but also similarities that suggest a global vaccine could be effective.

SourceUniversity of Connecticut·JournalThe Lancet Microbe·TypeExperimental study·DateSep 19, 2024

CNIC scientists discover a new cardiovascular risk factor and identify a drug able to reduce its effects

Researchers at CNIC discover clonal hematopoiesis as a new cause of atherosclerosis, while identifying the ancient medication colchicine as a potential treatment. Clonal hematopoiesis is linked to an increased risk of cardiovascular disease, with no influence on the progression of mutated blood cells.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateAug 30, 2024

Chronic cough may be hereditary

A study published at Uppsala University found that chronic cough is hereditary, with a 50% increased risk for offspring if one parent has the condition. The research also revealed differences in care between regions and highlights the need for better guidelines.

SourceUppsala University·JournalERJ Open Research·TypeObservational study·DateAug 22, 2024

Leading AI models struggle to identify genetic conditions from patient-written descriptions

Researchers found large language models are more accurate with concise, textbook-like medical questions than patient-written summaries. The models achieved higher accuracy when using standardized language, but struggled with variable phrasing and format of patient write-ups.

SourceNIH/National Human Genome Research Institute·JournalAmerican Journal of Human Genetics·TypeExperimental study·DateAug 14, 2024

A model of Collaborative Ethics to guide translational research from fundamental discoveries to real-world applications

The Collaborative Ethics model, developed by Jeantine Lunshof and Julia Rijssenbeek, aims to address ethical implications of emerging technologies from fundamental discoveries. By integrating philosophical and ethical reassessment into research processes, the model facilitates decision points for researchers and ethicists.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalNature Methods·TypeCommentary/editorial·DateJun 25, 2024

New findings for a better understanding of TRAF7 syndrome and patient care

The study provides a comprehensive understanding of TRAF7 syndrome, a rare neurological disorder characterized by cardiac, facial, and digital abnormalities. The research highlights the importance of comprehensive clinical assessment and proposes evidence-based guidelines for managing patients with TRAF7-related CAFDADD syndrome.

SourceUniversity of Barcelona·JournalPediatric Neurology·TypeRandomized controlled/clinical trial·DateApr 30, 2024

After 25 years, researchers uncover genetic cause of rare neurological disease

Scientists have identified the genetic mutation that causes SCA4, a progressive neurological disorder. The mutated gene ZFHX3 leads to impaired protein recycling in nerve cells, causing symptoms such as difficulty walking and balancing. This discovery opens the door to potential treatments for both SCA4 and another related form of ataxia.

SourceUniversity of Utah Health·JournalNature Genetics·TypeExperimental study·DateApr 29, 2024

Two new mutations identified as possible causes of rare blood disorder

Researchers discovered two novel GNE gene mutations that may cause a rare blood disorder called macrothrombocytopenia. The mutations affect the synthesis of sialic acid, critical for brain development and angiogenesis. Further studies are needed to understand the mechanism underlying this disorder and explore therapeutic interventions.

Chinese Medical Journal article unveils metabolic strategies to enhance CAR-T cell therapy

Researchers unveil innovative strategies to overcome metabolic constraints in CAR-T cell therapy, aiming to boost its efficacy in treating solid tumors. Metabolic interventions targeting immunosuppressive metabolites, metabolite uptake, and mitochondrial metabolism are proposed to enhance anti-tumor activity.

SourceCactus Communications·JournalChinese Medical Journal·TypeSystematic review·DateMar 26, 2024

Off-label use of a common antibiotic to treat muscular dystrophy

Researchers from Osaka University have identified erythromycin as a potential treatment for myotonic dystrophy type 1, a genetic disease characterized by progressive muscular weakness. The antibiotic showed acceptable safety and tolerability profiles in a phase 2 clinical trial, with some patients experiencing significant improvements ...

SourceOsaka University·JournalEClinicalMedicine·TypeRandomized controlled/clinical trial·DateDec 26, 2023

Researchers uncover why a gene mutant causes young children to have strokes

Researchers discovered that a mutation in the gene ACTA2 causes moyamoya disease and strokes in young children. The mutation leads to dysfunctional smooth muscle cells in arteries, resulting in blockages and increased risk of stroke. Understanding this mechanism could lead to new treatments for moyamoya disease.

SourceUniversity of Texas Health Science Center at Houston·JournalNature Cardiovascular Research·DateSep 28, 2023

Groundbreaking research unveils genetic characteristics and improved prognosis of triple negative apocrine carcinoma

Researchers identified distinct genomic characteristics that impact prognosis for patients with triple negative apocrine carcinoma. The study confirmed a five-year disease-free survival rate of 92.2% for these patients, significantly higher than those diagnosed with other types of TNBC.